✦ LIBER ✦
Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
✍ Scribed by Pamela Taxel; Robert Dowsett; Lee Richter; Pamela Fall; Alison Klepinger; Peter Albertsen
- Book ID
- 110922862
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 228 KB
- Volume
- 106
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.